Lantern Pharma Inc. (31)
Browse by Contract Category
Contracts
-
Third Amendment, dated August 1, 2022, to Employment Agreement with Panna Sharma dated July 23, 2018
(Filed With SEC on November 7, 2022)
-
Description of Capital Stock
(Filed With SEC on March 10, 2021)
-
Second Addendum to Technology License Agreement dated December 30, 2020 with AF Chemicals, LLC
(Filed With SEC on January 8, 2021)
-
API Services Project Agreement, dated July 10, 2020, between Patheon API Services, Inc. and Lantern Pharma Inc
(Filed With SEC on October 29, 2020)
-
Form of Lock-Up Agreement
(Filed With SEC on May 19, 2020)
-
Third Amendment, dated May 1, 2022, to Employment Agreement with Kishor Bhatia dated May 18, 2020
(Filed With SEC on August 8, 2022)
-
Second Amendment, dated May 1, 2022, to Employment Agreement with David Margrave dated May 18, 2020
(Filed With SEC on August 8, 2022)
-
Amendment to Employment Agreement dated February 18, 2021 with Kishor G. Bhatia
(Filed With SEC on March 10, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on January 8, 2021)
-
Amendment to Employment Agreement dated May 18, 2020 with Panna Sharma
(Filed With SEC on June 8, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on May 19, 2020)
-
Employment Agreement dated May 18, 2020 with Kishor G Bhatia
(Filed With SEC on May 19, 2020)
-
Employment Agreement dated May 18, 2020 with David Margrave
(Filed With SEC on May 19, 2020)
-
Amendment to Employment Agreement dated May 18, 2020 with Panna Sharma
(Filed With SEC on May 19, 2020)
-
Form of Amendment to Series A Preferred Stock Warrant
(Filed With SEC on May 19, 2020)
-
Specimen Stock Certificate evidencing shares of common stock
(Filed With SEC on May 12, 2020)
-
Form of Warrant (2017)
(Filed With SEC on April 16, 2020)
-
Addendum to Technology License Agreement dated February 8, 2016, with AF Chemicals, LLC
(Filed With SEC on April 16, 2020)
-
Assignment Agreement dated as of January 5, 2018 with BioNumerik Pharmaceuticals, Inc
(Filed With SEC on April 16, 2020)
-
Amendment No. 2 to Drug License and Development Agreement with Oncology Venture A/S dated February 11, 2016
(Filed With SEC on April 16, 2020)
-
Addendum to Drug License and Development Agreement with Oncology Venture A/S dated February 8, 2016
(Filed With SEC on April 16, 2020)
-
Drug License and Development Agreement dated as of May 23, 2015 with Oncology Venture A/S
(Filed With SEC on April 16, 2020)
-
Technology License Agreement dated January 15, 2015, with AF Chemicals, LLC
(Filed With SEC on April 16, 2020)
-
Amended and Restated Voting Agreement
(Filed With SEC on April 16, 2020)
-
Amended and Restated Right of First Refusal and Co-Sale Agreement
(Filed With SEC on April 16, 2020)
-
Amended and Restated Investors Rights Agreement
(Filed With SEC on April 16, 2020)
-
Form of Indemnification Agreement
(Filed With SEC on April 16, 2020)
-
Employment Agreement dated July 23, 2018 with Panna Sharma
(Filed With SEC on April 16, 2020)
-
Amended and Restated 2018 Equity Incentive Plan
(Filed With SEC on April 16, 2020)
-
Form of Warrant (2019)
(Filed With SEC on April 16, 2020)
-
Form of Warrant (2014)
(Filed With SEC on April 16, 2020)